| Financial Year |
March 31 2023 |
| Monetary Funds |
321,468,056.06 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
386,441,433.19 |
| Accounts Receivable |
821,048,974.38 |
| Advances to Suppliers |
199,638,300.33 |
| Other Receivables |
55,981,840.99 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
539,079,905.96 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
156,781,528.02 |
| Total Current Assets |
3,779,394,788.21 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
71,597,929.54 |
| Investment Properties |
-- |
| Fixed Assetes |
773,743,446.26 |
| Under-construction Projects |
297,558,731.37 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
167,965,376.61 |
| R&D expenses |
73,530,607.90 |
| Goodwill |
547,348,817.11 |
| Long-Term Deferred and Prepaid Expenses |
7,572,051.37 |
| Deferred Income Tax Assets |
165,812,779.02 |
| Other Non-Current Assets |
35,081,883.04 |
| Sub-Total of Non-Current Assets |
2,168,790,029.78 |
| Total Assets |
5,948,184,817.99 |
| Short-Term Loans |
1,152,850,655.58 |
| Trading Financial liabilities |
-- |
| Notes Payable |
316,529,689.60 |
| Accounts Payable |
785,514,541.94 |
| Accounts Received In Advance |
3,192,758.61 |
| Employee Compensation Payable |
18,046,308.78 |
| Taxes Payable |
31,753,183.20 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
134,775,449.46 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
181,062,086.12 |
| Other Current Liabilities |
312,497,653.75 |
| Sub-Total of Current Liabilities |
3,153,017,555.61 |
| Long-term Loans |
297,266,447.92 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
4,563,663.82 |
| Special Payable |
-- |
| Estimatied Liabilities |
46,989,013.80 |
| Deferred Income Tax Liabilities |
5,158,203.13 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
407,109,022.32 |
| Total Liabilities |
3,560,126,577.93 |
| Paid-In Capital(Or Share Stock) |
1,489,164,214.00 |
| Capital Surplus |
1,349,573,775.63 |
| Surplus Reserve |
44,048,643.09 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-495,084,670.69 |
| Minority Stockholder's Interest |
-2,084,584.52 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,390,142,824.58 |
| Owner's Equity（Stockholder's Equity） |
2,388,058,240.06 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
5,948,184,817.99 |
